Lord, Abbett & Co
HPTX

Lord, Abbett & Co’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Lord, Abbett & Co’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-192,719
Closed -$5.03M – 1090
2014
Q2 		$5.03M Buy
192,719
+35,732
+23% +$919K 0.01% 799
2014
Q1 		$4.05M Buy
+156,987
New +$4.25M 0.01% 829

Other funds holding HPTX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
HMPV
Highland Management Partners VII Cambridge, Massachusetts $5.57M AUM 94.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lord, Abbett & Co's HPTX Position: Q3 2014 in Review

Lord, Abbett & Co sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q3 2014, closing a stake of 192,719 shares — an estimated $5.03M sold.

Lord, Abbett & Co first reported a position in HPTX in Q1 2014 and held it in 2 quarters. The position peaked at $5.03M in Q2 2014. 97 funds tracked by Wall St. Rank hold HPTX as of Q3 2014.

  • Lord, Abbett & Co reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Lord, Abbett & Co sold 192,719 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q3 2014, an estimated $5.03M.
  • Lord, Abbett & Co first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q1 2014 and held it in 2 quarters.
  • Lord, Abbett & Co's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $5.03M in Q2 2014.
  • 97 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q3 2014.

Based on Lord, Abbett & Co's 13F filing for Q3 2014, filed 14 Nov 2014.